Prestige Brands traded at $61.45 this Friday March 13th, decreasing $0.45 or 0.73 percent since the previous trading session. Looking back, over the last four weeks, Prestige Brands lost 7.27 percent. Over the last 12 months, its price fell by 26.57 percent. Looking ahead, we forecast Prestige Brands to be priced at 59.59 by the end of this quarter and at 54.36 in one year, according to Trading Economics global macro models projections and analysts expectations.
Prestige Consumer Healthcare Inc. is engaged in the marketing, sales and distribution of over the counter (OTC) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada), and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.